リウマティック・ミトラル・ステノシスにおける左心房血栓: 国際標準化比率の治療不全の事例
Muhammad Salman Sabri1, Carly Weber2, Yanis Belkadi3
1Department of Internal Medicine, Jefferson Abington Hospital, Abington, Pennsylvania, USA.
JACC. Case reports
|September 5, 2025
まとめ
リウマティック・ミトラス狭窄症と心房動症の患者は,抗凝固薬を使用しても,左心房動症のリスクが高くなります. トランスエゾファギアルエコーカルディオグラムは心臓転換前において,これらの高リスクの個体において,血栓を検出するために極めて重要です.
科学分野:
- 心臓病科
- 心臓の電気生理学
- 医療用イメージング
背景:
- リウマティック・ミトラル狭窄症 (MS) は,特に心房動または動の患者で,左心房付属体 (LAA) 血栓のリスクの増加と関連しています.
- この患者集団において,治療的抗凝固剤は必ずしもLAA血栓形成を防ぐとは限りません.
- 左心房 (LA) の血栓は,栓塞性イベントの重大なリスクを伴います.
研究 の 目的:
- リウマチ性MSと心房振動の患者におけるLAA血栓の危険性を強調する.
- この特定の患者群において,心臓転換前における食道横断エコーカルジオグラム (TEE) の重要性を強調する.
- リウマチ性MSの文脈におけるLAA血栓の管理戦略について議論する.
主な方法:
- 呼吸不全を伴う中度性多発性硬化症の 72歳の女性の症例です
- 診断評価には,LAA血栓の有無を判断するトランス食道回響図 (TEE) が含まれていた.
- 治療には,抗凝固目標の調整と心臓転換の延期が含まれていました.
主要な成果:
- 大量のLAA血栓は,国際標準比率 (INR) >2.5にもかかわらず,リウマチ性MSと心房振動の患者でTEEで特定されました.
- LAA血栓の存在により,心臓転換は延期された.
- 治療目的のINRは2. 5から3. 5に増加した.
結論:
- リウマチ性MSと並行する心房動の患者は,LAAとLA血栓の高いリスクがあり,心臓転換前にTEEが必要になります.
- リウマチ性MSの患者の心臓転換の決定は,TEEの発見によって導かれ,血栓のリスクを軽減する必要があります.
- リウマティック・MSにおけるLAA血栓の最適な治療法 (手術を含む) を決定するには,さらなる研究が必要である.
さらに関連する動画
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
10.5K
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.6K
関連する概念動画
01:26Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
01:22Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
54
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
54
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
36
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
36
01:25Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31